Original Query: ALL
Previous Study | Return to List | Next Study

A Study of Aleglitazar in Monotherapy in Patients With Type 2 Diabetes Mellitus Who Are Drug-Naïve to Anti-Hyperglycemic Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01871428
Recruitment Status : Completed
First Posted : June 6, 2013
Last Update Posted : November 2, 2016
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2013
  Study Completion Date : November 2013
  Certification/Extension First Submitted : August 9, 2016